Koimtzis Georgios, Stefanopoulos Leandros, Geropoulos Georgios, Papavramidis Theodosios
Department of General Surgery, Royal Glamorgan Hospital, Cardiff, UK.
Department of Electrical and Computer Engineering, Northwestern University, Evanston, IL, USA.
Endocrine. 2025 Jan;87(1):27-38. doi: 10.1007/s12020-024-04011-y. Epub 2024 Aug 24.
Thyroidectomy is the treatment of choice for malignant thyroid diseases as well as for benign conditions who cannot be treated medically. The most common complication following thyroidectomy is hypocalcaemia and hypoparathyroidism that usually results from accidental damage or removal of one or more parathyroid glands. Parathyroid gland autotransplantation has been one of the most common intraoperative strategies applied to tackle this problem. The aim of this study is to assess whether parathyroid auto trasnplantation is associated with a decrease in postoperative hypoparathyroidism following thyroidectomy.
We conducted a thorough systematic review and meta-analysis of relevant studies published up to February 2024 in MEDLINE, Scopus, Embase and Cochrane Library databases. We compared the incidence of postoperative hypoparathyroidism between the group of patients who underwent autotransplantation and the patients were the parathyroid glands were preserved in situ. A trial sequential analysis was performed subsequently to confirm the findings.
Eighteen studies fulfilled all the inclusion criteria and were ultimately included in our study. The total number of patients was 8,182 with 4,029 receiving parathyroid gland autotransplantation. Autotransplantation was associated with a higher incidence of immediate (within 24 h) and transient hypoparathyroidism (RR 1.58, 1.45-1.73, CI 95%, p < 0.00 and RR 1.60, 1.47-1.76, CI 95%, p < 0.001, respectively). However, it did not affect the rate of permanent postoperative hypoparathyroidism (RR 0.85, 0.51-1.41, CI 95%, p = 0.54). The subsequent trial sequential analysis confirmed these findings.
Parathyroid autotransplantation does not lead to a decrease in the rate of permanent post-thyroidectomy hypoparathyroidism. The most important factor to decrease its incidence remains the accurate identification and preservation of the parathyroid glands intraoperatively.
甲状腺切除术是治疗恶性甲状腺疾病以及无法通过药物治疗的良性疾病的首选方法。甲状腺切除术后最常见的并发症是低钙血症和甲状旁腺功能减退,这通常是由于意外损伤或切除一个或多个甲状旁腺所致。甲状旁腺自体移植一直是解决这一问题最常用的术中策略之一。本研究的目的是评估甲状旁腺自体移植是否与甲状腺切除术后甲状旁腺功能减退的发生率降低有关。
我们对截至2024年2月在MEDLINE、Scopus、Embase和Cochrane图书馆数据库中发表的相关研究进行了全面的系统评价和荟萃分析。我们比较了接受自体移植的患者组和甲状旁腺原位保留的患者组术后甲状旁腺功能减退的发生率。随后进行了试验序贯分析以证实研究结果。
18项研究符合所有纳入标准,最终纳入我们的研究。患者总数为8182例,其中4029例接受了甲状旁腺自体移植。自体移植与即刻(24小时内)和短暂性甲状旁腺功能减退的发生率较高相关(相对风险分别为1.58,1.45 - 1.73,95%置信区间,p < 0.001和相对风险1.60,1.47 - 1.76,95%置信区间,p < 0.001)。然而,它并不影响术后永久性甲状旁腺功能减退的发生率(相对风险0.85,0.51 - 1.41,95%置信区间,p = 0.54)。随后的试验序贯分析证实了这些结果。
甲状旁腺自体移植并不会降低甲状腺切除术后永久性甲状旁腺功能减退的发生率。降低其发生率的最重要因素仍然是术中准确识别和保留甲状旁腺。